Back
Neurocrine Biosciences Inc (NBIX)
BiotechnologyNBIX · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$153.34
+0.22%Weekly undervalued picks (like NBIX)
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$4.67
ROE
22.5%
Gross margin
64.4%
Debt/Equity
0.14x
Revenue growth
42.2%
Neurocrine Biosciences Inc — company intelligence
Earnings surprises
Q2 2026$1.39 vs $1.37 est+1.5%
Q1 2026$1.91 vs $1.20 est+59.5%
Q4 2025$1.91 vs $1.20 est+59.5%
Q3 2025$2.04 vs $1.62 est+26.1%
Analyst consensus · 36 analysts
31 Buy5 Hold0 Sell
Updated Aug 22, 2026
Insider activity · 90 days
0 buys13 sellsnet -66,170 shares
Onyia Judegift 2,409 · Aug 4, 2026
Norwalk Leslie Vother 842 · Jul 29, 2026
Norwalk Leslie VSell 1,250 · Jul 28, 2026
Recent SEC filings
4 — Insider transaction reportAug 5, 2026
10-Q — Quarterly reportJul 31, 2026
4 — Insider transaction reportJul 30, 2026
Latest news
Neurocrine Biosciences: 'House Full Of Options' — SeekingAlpha · 4d ago
Jim Cramer Says Buy Uber, Calls Rockwell Automation 'One Ugly Chart' but a 'Great Long-Term Situation' — Benzinga · 1w ago
NBIX Stock Dips 12% in a Month: Time to Buy, Hold or Sell? — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks (like NBIX)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.